Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.
Also called NCT01710007
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 202 participants
- Sponsor
- Orient Pharma Co., Ltd.
- Registry
-
NCT01710007
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01710007. Randomized; double masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2023-07-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- 1PC002
- Intervention (Drug)
- Lipitor
- Lead sponsor
- Orient Pharma Co., Ltd.
- Collaborator
- Orient Europharma Co., Ltd.
Record details
- Record id
cardio:ct-nct01710007- Content hash
d49eb4eb2922764d321d0853c2ee765c98fa520c073f433ed0ce962e6b2a04b2